Stéphane De Lombaert

Author

Boehringer Ingelheim (United States)

Also Known As

De Lombaert, Stéphane, Stephane De Lombaert, Stéphane De Lombaert

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (United States)Novartis (United States)Vion Pharmaceuticals (United States)Novartis (Switzerland)Tris Pharma (United States)

About

Stéphane De Lombaert is an author at Boehringer Ingelheim (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	32	996
2	Biochemistry	20	29	958
3	Natural Sciences	18	23	801
4	Engineering	4	4	138
5	Social Sciences	1	1	20

Stéphane De Lombaert

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action Stéphane De Lombaert, Louis Blanchard, Lisa B. Stamford, Journal of Medicinal Chemistry Cgs 35066Selective Non-peptidic InhibitorsPharmacotherapyChemical BiologyPharmaceutical Chemistry	2000	100
N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors Stéphane De Lombaert, Mark D. Erion, Jenny Tan, Journal of Medicinal Chemistry	1994	79
Photolytic reactions of chromium aminocarbene complexes. Conversion of amides to .alpha.-amino acids Louis S. Hegedus, Mark A. Schwindt, Stéphane De Lombaert, Journal of the American Chemical Society Chemical EngineeringMedicinal Chemistry.Alpha.-amino AcidsEngineeringPhotochemistry	1990	71
Three-Dimensional Models of ACE and NEP Inhibitors and Their Use in the Design of Potent Dual ACE/NEP Inhibitors Regine S. Bohacek, Stéphane De Lombaert, Colin McMartin, Journal of the American Chemical Society	1996	70
Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase Anne B. Eldrup, Fariba Soleymanzadeh, Steven J. Taylor, Journal of Medicinal Chemistry Lipid PeroxidationMetabolomic ProfilingStructure-based OptimizationEnzymatic ModificationRedox Biology	2009	69
Non-peptidic inhibitors of neutral endopeptidase 24.11 1. Discovery and optimization of potency Stéphane De Lombaert, Louis Blanchard, Jenny Tan, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicinePeptoid	1995	60
Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension Robert J. Aiello, Patricia-Ann K. Bourassa, Qing Zhang, Journal of Pharmacology and Experimental Therapeutics	2016	57
Methyl 3-phenylsulfonyl orthopropionate: A new reagent for cyclopentannulation Stéphane De Lombaert, I. Nemery, B. Roekens, Tetrahedron Letters HeterocyclicOrganic ChemistryNew ReagentPharmacologyEnantioselective Synthesis	1986	56
5-Aminomethylbenzimidazoles as potent ITK antagonists Doris Riether, Renée Zindell, Jennifer A. Kowalski, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceMedicinePotent Itk AntagonistsPharmacological Agent	2009	44
Selective Inhibitors of G2019S-LRRK2 Kinase Activity Albert W. Garofalo, Jessica Bright, Stéphane De Lombaert, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetG Protein-coupled ReceptorMedicineReceptor Tyrosine Kinase	2020	44

Page 1